CD4 and common variable immunodeficiency: von Spee-Mayer et al, reported that a reduction in naïve CD4 T cells to less than 10% had the highest sensitivity of all tested markers for patients with clinical complications often associated with CID, although the authors admitted that none of the current definitions sufficiently separates CID from CVID patients (56).